Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study.

dc.contributor.author

Wu, Li-Tzy

dc.contributor.author

Blazer, Dan G

dc.contributor.author

Patkar, Ashwin A

dc.contributor.author

Stitzer, Maxine L

dc.contributor.author

Wakim, Paul G

dc.contributor.author

Brooner, Robert K

dc.date.accessioned

2020-02-03T06:04:01Z

dc.date.available

2020-02-03T06:04:01Z

dc.date.issued

2009-05

dc.date.updated

2020-02-03T06:04:00Z

dc.description.abstract

We investigated the presence of DSM-IV subtyping for dependence on cocaine and amphetamines (with versus without physical dependence) among outpatient stimulant users enrolled in a multisite study of the Clinical Trials Network (CTN). Three mutually exclusive groups were identified: primary cocaine users (n = 287), primary amphetamine users (n = 99), and dual users (cocaine and amphetamines; n = 29). Distinct subtypes were examined with latent class and logistic regression procedures. Cocaine users were distinct from amphetamine users in age and race/ethnicity. There were four distinct classes of primary cocaine users: non-dependence (15%), compulsive use (14%), tolerance and compulsive use (15%), and physiological dependence (tolerance, withdrawal, and compulsive use; 56%). Three distinct classes of primary amphetamine users were identified: non-dependence (11%), intermediate physiological dependence (31%), and physiological dependence (58%). Regardless of stimulants used, most female users were in the most severe or the physiological dependence group. These results lend support for subtyping dependence in the emerging DSM-V.

dc.identifier

910143855

dc.identifier.issn

1055-0496

dc.identifier.issn

1521-0391

dc.identifier.uri

https://hdl.handle.net/10161/20009

dc.language

eng

dc.publisher

Wiley

dc.relation.ispartof

The American journal on addictions

dc.relation.isversionof

10.1080/10550490902787031

dc.subject

Humans

dc.subject

Amphetamine-Related Disorders

dc.subject

Cocaine-Related Disorders

dc.subject

Substance Withdrawal Syndrome

dc.subject

Severity of Illness Index

dc.subject

Age Factors

dc.subject

Comorbidity

dc.subject

Sex Distribution

dc.subject

Drug Tolerance

dc.subject

Models, Psychological

dc.subject

Diagnostic and Statistical Manual of Mental Disorders

dc.subject

Adult

dc.subject

Female

dc.subject

Male

dc.title

Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study.

dc.type

Journal article

duke.contributor.orcid

Wu, Li-Tzy|0000-0002-5909-2259

pubs.begin-page

206

pubs.end-page

218

pubs.issue

3

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Center for Child and Family Policy

pubs.organisational-group

Sanford School of Public Policy

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Psychiatry & Behavioral Sciences, Social and Community Psychiatry

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Medicine

pubs.organisational-group

Center for the Study of Aging and Human Development

pubs.organisational-group

Family Medicine and Community Health

pubs.organisational-group

Psychiatry & Behavioral Sciences, Geriatric Behavioral Health

pubs.organisational-group

Family Medicine and Community Health, Community Health

pubs.publication-status

Published

pubs.volume

18

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Wu 2009 Heterogeneity of stimulant dependence a national drug abuse treatment clinical trials network study..pdf
Size:
577.29 KB
Format:
Adobe Portable Document Format